<?xml version="1.0" encoding="UTF-8"?>
<p>Although we have found very few publications related to these activities, in some cases the antioxidant activity of coumarin derivatives of both natural [
 <xref rid="B28-molecules-26-00501" ref-type="bibr">28</xref>] and synthetic [
 <xref rid="B29-molecules-26-00501" ref-type="bibr">29</xref>] origin has been reported. This is the case of NOs inhibitors, an activity described for coumarins that bind through different linkers to phenolic fragments capable of acting as radical scavengers (
 <xref ref-type="fig" rid="molecules-26-00501-f004">Figure 4</xref>, general structure 
 <bold>XVII</bold>), hybrids that can therefore be used in the treatment of immunomodulatory diseases.
</p>
